Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatigue Syndrome, Chronic | 4 | 2023 | 215 | 0.610 |
Why?
|
| Syphilis | 3 | 2010 | 243 | 0.420 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 2 | 2024 | 53 | 0.420 |
Why?
|
| Eye Infections, Bacterial | 1 | 2010 | 242 | 0.290 |
Why?
|
| Penicillanic Acid | 1 | 2024 | 42 | 0.230 |
Why?
|
| Ceftriaxone | 2 | 2014 | 175 | 0.210 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2019 | 19 | 0.170 |
Why?
|
| Tinea Capitis | 1 | 2019 | 15 | 0.170 |
Why?
|
| Anaerobic Threshold | 1 | 2019 | 51 | 0.170 |
Why?
|
| Sweat Glands | 1 | 2019 | 33 | 0.160 |
Why?
|
| Family Practice | 1 | 2021 | 509 | 0.160 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2019 | 158 | 0.150 |
Why?
|
| Heart Rate | 3 | 2022 | 4190 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2019 | 386 | 0.130 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 835 | 0.120 |
Why?
|
| Myiasis | 1 | 1993 | 14 | 0.110 |
Why?
|
| Fats | 1 | 1993 | 99 | 0.110 |
Why?
|
| Exercise Test | 1 | 2021 | 2127 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2022 | 1886 | 0.110 |
Why?
|
| HIV-1 | 1 | 2010 | 6859 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2014 | 1468 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 6 | 1987 | 2199 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 2728 | 0.100 |
Why?
|
| Acyclovir | 3 | 1986 | 268 | 0.090 |
Why?
|
| Meat | 1 | 1993 | 585 | 0.090 |
Why?
|
| Leukemia Virus, Murine | 1 | 2010 | 94 | 0.090 |
Why?
|
| Retroviridae Infections | 1 | 2010 | 147 | 0.090 |
Why?
|
| Eye Infections | 1 | 2010 | 62 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2022 | 8479 | 0.080 |
Why?
|
| Retinitis | 2 | 1986 | 36 | 0.080 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1995 | 662 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 3246 | 0.080 |
Why?
|
| Infectious Mononucleosis | 2 | 1985 | 133 | 0.070 |
Why?
|
| HIV Infections | 3 | 2010 | 17328 | 0.070 |
Why?
|
| Tumor Virus Infections | 1 | 2010 | 438 | 0.070 |
Why?
|
| Neurosyphilis | 1 | 1987 | 27 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 1995 | 1403 | 0.070 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2005 | 29 | 0.060 |
Why?
|
| Onchocerciasis | 1 | 2005 | 28 | 0.060 |
Why?
|
| Cytomegalovirus | 3 | 1985 | 755 | 0.060 |
Why?
|
| Vaginitis | 1 | 2005 | 49 | 0.060 |
Why?
|
| Fatigue | 2 | 2023 | 1550 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 4 | 1986 | 831 | 0.060 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 855 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2569 | 0.060 |
Why?
|
| Trichomonas Vaginitis | 2 | 2005 | 33 | 0.050 |
Why?
|
| Exercise | 1 | 2019 | 5874 | 0.050 |
Why?
|
| Orthostatic Intolerance | 1 | 2022 | 23 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2010 | 2846 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 1896 | 0.050 |
Why?
|
| Vaginosis, Bacterial | 2 | 2005 | 151 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2005 | 560 | 0.050 |
Why?
|
| Adult | 17 | 2023 | 220781 | 0.050 |
Why?
|
| Ichthyosis | 1 | 2019 | 59 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2013 | 7424 | 0.040 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 1998 | 25 | 0.040 |
Why?
|
| Middle Aged | 13 | 2022 | 220382 | 0.040 |
Why?
|
| Biopsy | 2 | 2021 | 6765 | 0.040 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2019 | 379 | 0.040 |
Why?
|
| Humans | 28 | 2024 | 760437 | 0.040 |
Why?
|
| Pulmonary Ventilation | 1 | 2019 | 372 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2022 | 701 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1985 | 2610 | 0.040 |
Why?
|
| Male | 18 | 2022 | 360035 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 6168 | 0.040 |
Why?
|
| Antiviral Agents | 2 | 1985 | 3066 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2005 | 1931 | 0.030 |
Why?
|
| Leukocyte Count | 3 | 2010 | 1596 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 2 | 2010 | 544 | 0.030 |
Why?
|
| Female | 13 | 2024 | 391875 | 0.030 |
Why?
|
| Disease Notification | 1 | 1995 | 95 | 0.030 |
Why?
|
| Furunculosis | 1 | 1993 | 5 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2024 | 80430 | 0.030 |
Why?
|
| Ganciclovir | 3 | 1986 | 252 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 1985 | 10188 | 0.020 |
Why?
|
| Cardiolipins | 1 | 2010 | 81 | 0.020 |
Why?
|
| Homosexuality | 2 | 1987 | 267 | 0.020 |
Why?
|
| Deltaretrovirus | 2 | 1985 | 162 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2010 | 405 | 0.020 |
Why?
|
| Meningitis | 2 | 1987 | 218 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2010 | 532 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5075 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 1648 | 0.020 |
Why?
|
| Fundus Oculi | 2 | 1986 | 548 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 3880 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26063 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16585 | 0.020 |
Why?
|
| Dyspnea | 1 | 2014 | 1344 | 0.020 |
Why?
|
| Filaricides | 1 | 2005 | 10 | 0.020 |
Why?
|
| Penicillin G Benzathine | 1 | 2005 | 25 | 0.020 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2005 | 37 | 0.020 |
Why?
|
| Hydroxides | 1 | 2005 | 46 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2019 | 9309 | 0.020 |
Why?
|
| Ivermectin | 1 | 2005 | 46 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 2005 | 42 | 0.020 |
Why?
|
| Paralysis | 1 | 1987 | 250 | 0.020 |
Why?
|
| Nerve Tissue | 1 | 1985 | 78 | 0.020 |
Why?
|
| DNA Probes | 1 | 2005 | 544 | 0.010 |
Why?
|
| Half-Life | 1 | 1985 | 652 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1995 | 2603 | 0.010 |
Why?
|
| Metronidazole | 1 | 2005 | 232 | 0.010 |
Why?
|
| Aortography | 1 | 2005 | 420 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 59068 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2010 | 2201 | 0.010 |
Why?
|
| Swine | 1 | 1993 | 5915 | 0.010 |
Why?
|
| Aged | 4 | 2019 | 168840 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1985 | 285 | 0.010 |
Why?
|
| Chlamydia Infections | 1 | 2005 | 365 | 0.010 |
Why?
|
| Neutrophils | 2 | 1985 | 3764 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2902 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6086 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12320 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2010 | 1154 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2005 | 1257 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1668 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1987 | 2300 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 984 | 0.010 |
Why?
|
| Aorta | 1 | 2005 | 2042 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8826 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 20078 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 64591 | 0.010 |
Why?
|
| Cross Infection | 1 | 1985 | 1438 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 1998 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1985 | 1654 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3759 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1984 | 2123 | 0.010 |
Why?
|
| Monocytes | 1 | 1984 | 2572 | 0.010 |
Why?
|
| United States | 2 | 2005 | 72202 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 5966 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 5491 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5663 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39078 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12969 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 41366 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1984 | 9176 | 0.000 |
Why?
|
| Ophthalmoscopy | 1 | 1986 | 171 | 0.000 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1985 | 55 | 0.000 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1985 | 114 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1985 | 234 | 0.000 |
Why?
|
| Punctures | 1 | 1985 | 366 | 0.000 |
Why?
|
| Accidents, Occupational | 1 | 1985 | 249 | 0.000 |
Why?
|
| Antibodies, Viral | 2 | 1985 | 3155 | 0.000 |
Why?
|
| Spinal Cord Diseases | 1 | 1985 | 293 | 0.000 |
Why?
|
| New York | 1 | 1985 | 872 | 0.000 |
Why?
|
| Pathology | 1 | 1985 | 270 | 0.000 |
Why?
|
| Needles | 1 | 1985 | 451 | 0.000 |
Why?
|
| Animals | 1 | 1993 | 168253 | 0.000 |
Why?
|
| Research Personnel | 1 | 1985 | 587 | 0.000 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1985 | 710 | 0.000 |
Why?
|
| Syndrome | 1 | 1985 | 3267 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1985 | 1952 | 0.000 |
Why?
|
| Neutropenia | 1 | 1984 | 884 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1984 | 1078 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1985 | 3800 | 0.000 |
Why?
|
| Pregnancy | 1 | 1998 | 29831 | 0.000 |
Why?
|
| Acute Disease | 1 | 1985 | 7230 | 0.000 |
Why?
|
| Endoscopy | 1 | 1985 | 1849 | 0.000 |
Why?
|
| Risk | 1 | 1985 | 9605 | 0.000 |
Why?
|
| Boston | 1 | 1985 | 9326 | 0.000 |
Why?
|
| Dementia | 1 | 1985 | 2679 | 0.000 |
Why?
|
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_